Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic
| Errataetall: |
CommentIn: J Neurol Sci. 2020 Jul 15;414:116888. - PMID 32413767 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:412 |
|---|---|
| Enthalten in: |
Journal of the neurological sciences - 412(2020) vom: 15. Mai, Seite 116803 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
International MG/COVID-19 Working Group [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Immunoglobulins, Intravenous |
|---|
| Anmerkungen: |
Date Completed 28.04.2020 Date Revised 07.12.2022 published: Print-Electronic CommentIn: J Neurol Sci. 2020 Jul 15;414:116888. - PMID 32413767 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jns.2020.116803 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM308325990 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM308325990 | ||
| 003 | DE-627 | ||
| 005 | 20231225131510.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jns.2020.116803 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1027.xml |
| 035 | |a (DE-627)NLM308325990 | ||
| 035 | |a (NLM)32247193 | ||
| 035 | |a (PII)S0022-510X(20)30139-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a International MG/COVID-19 Working Group |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.04.2020 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: J Neurol Sci. 2020 Jul 15;414:116888. - PMID 32413767 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Practice Guideline | |
| 650 | 7 | |a Immunoglobulins, Intravenous |2 NLM | |
| 650 | 7 | |a Immunologic Factors |2 NLM | |
| 650 | 7 | |a Immunosuppressive Agents |2 NLM | |
| 650 | 7 | |a Vaccines |2 NLM | |
| 700 | 1 | |a Jacob, Saiju |e verfasserin |4 aut | |
| 700 | 1 | |a Muppidi, Srikanth |e verfasserin |4 aut | |
| 700 | 1 | |a Guidon, Amanda |e verfasserin |4 aut | |
| 700 | 1 | |a Guptill, Jeffrey |e verfasserin |4 aut | |
| 700 | 1 | |a Hehir, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Howard, James F |c Jr |e verfasserin |4 aut | |
| 700 | 1 | |a Illa, Isabel |e verfasserin |4 aut | |
| 700 | 1 | |a Mantegazza, Renato |e verfasserin |4 aut | |
| 700 | 1 | |a Murai, Hiroyuki |e verfasserin |4 aut | |
| 700 | 1 | |a Utsugisawa, Kimiaki |e verfasserin |4 aut | |
| 700 | 1 | |a Vissing, John |e verfasserin |4 aut | |
| 700 | 1 | |a Wiendl, Heinz |e verfasserin |4 aut | |
| 700 | 1 | |a Nowak, Richard J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the neurological sciences |d 1964 |g 412(2020) vom: 15. Mai, Seite 116803 |w (DE-627)NLM000061956 |x 1878-5883 |7 nnns |
| 773 | 1 | 8 | |g volume:412 |g year:2020 |g day:15 |g month:05 |g pages:116803 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jns.2020.116803 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 412 |j 2020 |b 15 |c 05 |h 116803 | ||